-
Mashup Score: 0In My Mother’s Eyes: Her Ocular Melanoma Story - 7 month(s) ago
Ocular melanoma is very different from melanoma skin cancer. Read about this rare form of melanoma also known as uveal melanoma.
Source: www.skincancer.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Eye Believe Survivorship Seminar - Seattle, WA - 8 month(s) ago
Eye Believe 2023 Survivorship Seminar
Source: events.zoom.usCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Join us in #Seattle (or online) on Sept 8-9 for a free seminar about #OcularMelanoma! Fred Hutch physicians @EvanHallMD, @BhatiaS_MD and Jonathan Chen, MD, PhD, join a lineup of experts to provide patients the tools to not only survive, but thrive. https://t.co/PNHAZyySyN
-
-
Mashup Score: 0Retinal Physician June 2023 Page 23 - 10 month(s) agoSource: digital.retinalphysician.comCategories: Latest Headlines, OphthalmologyTweet
-
The June issue offers an update on treatments for #ocularmelanoma that go beyond brachytherapy and radiotherapy. Read more in the digital edition: https://t.co/xqMAN9UBU8 #ocularoncology #ophthalmology https://t.co/EsPlZq6SE4
-
-
Mashup Score: 0Hope Is Paramount During Uveal Melanoma Treatment - 10 month(s) ago
An expert gives an overview of the treatment options for uveal melanoma, and why he considers hope to be an essential part of the care plan.
Source: Cure TodayCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
R. Christopher Bowen, MD, (@EyecancerMD) of @LurieCancer @NorthwesternMed discusses #uvealmelanoma treatment options and support to help patients live as long and as well as possible with this rare diagnosis. https://t.co/G0FqiMyndT via @curetoday #ocularmelanoma
-
-
Mashup Score: 0
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma – Full Text View.
Source: clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet-
Now accruing for #ocularmelanoma @Novocure @bmsnews tumor treatment fields with #ipilimumab #nivolumab . (Prior checkpoint allowed) amazing opportunity for patients. @Mi_onc seen here primary investigator @angelesclinic imehmi@theangelesclinic.org https://t.co/EqAJq8w9cG https://t.co/TdO8JnOtIf
-
-
Mashup Score: 0
Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Uveal or #OcularMelanoma is a rare, aggressive tumor of the eye. Dr. Marlana Orloff is PI of a phase 1/1b study of the investigational drug SD-101 alone or with an immune checkpoint blockade to treat metastatic #UvealMelanoma. #TrialTuesday #RareDiseaseDay https://t.co/CkFCXihM7F https://t.co/CN6GEkHO2i
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
This week we are sharing the most-read articles for each month in #2022. The #Bestof January was: Searching for Therapies to Treat Rare #OcularMelanoma: https://t.co/Au3vJg6NGM #Oncology #MedTwitter #Bestof2022 https://t.co/SAmpITRxE2
-
-
Mashup Score: 1The Cancer News Daily - 1 year(s) ago
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest The Cancer News Daily! https://t.co/PzMO3g8xDv Thanks to @RoswellPark @Aiims1742 @AACRFoundation #pancreaticcancer #ocularmelanoma
-
-
Mashup Score: 3IGF1R inhibition enhances the therapeutic effects of Gq/11 inhibition in metastatic uveal melanoma progression - 1 year(s) ago
Abstract. Uveal melanoma (UM) is the most common intraocular tumor in adults and up to 50% of patients develop metastatic disease, which remains uncurable. Since metastatic UM patients have an average survival of less than 1 year after diagnosis, there is an urgent need to develop new treatment strategies. While activating mutations in Galphaq or Galpha11 proteins are major drivers of…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Research from SKCC & @JeffersonUniv's Dr. Jeff Benovic & team suggests that the combination of Galphaq/11 & insulin-like growth factor 1 inhibition provides a promising therapeutic strategy to treating metastatic #UvealMelanoma: https://t.co/iTtYypcN2h @MCT_AACR #OcularMelanoma https://t.co/1864mTebBQ
-
-
Mashup Score: 0
With an overall response rate of 50% and greater than 5 months median progression-free survival in patients with first-line metastatic uveal melanoma, darovasertib and crizotinib shows a compelling clinical efficacy profile.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Interim results of a phase 2 #ClinicalTrial evaluating darovasertib & crizotinib synthetic lethal combination showed clinical efficacy in patients with metastatic #UvealMelanoma. Dr. Marlana Orloff is leading the study at SKCC: https://t.co/o1PpFwDxhV @TargetedOnc #OcularMelanoma
-
Ocular or uveal (meaning "of the eye") melanoma is very different from cutaneous ("of the skin") melanoma. Learn more about this rare form of #melanoma. https://t.co/9zigDdxQ91 #ocularmelanoma